Progress in secondary prevention of stroke with PROGRESS

被引：9

作者：

Schiffrin, EL

机构：

来源：

CURRENT HYPERTENSION REPORTS | 2002年 / 4卷 / 01期

关键词：

D O I：

10.1007/s11906-002-0051-0

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：39 / 40

页数：2

共 5 条

[1] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].

COLLINS, R ;

PETO, R ;

MACMAHON, S ;

HEBERT, P ;

FIEBACH, NH ;

EBERLEIN, KA ;

GODWIN, J ;

QIZILBASH, N ;

TAYLOR, JO ;

HENNEKENS, CH .

LANCET, 1990, 335 (8693) :827-838

[2] Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].

Hansson, L ;

Lindholm, LH ;

Niskanen, L ;

Lanke, J ;

Hedner, T ;

Niklason, A ;

Luomanmäki, K ;

Dahlöf, B ;

de Faire, U ;

Mörlin, C ;

Karlberg, BE ;

Wester, PO ;

Björck, JE .

LANCET, 1999, 353 (9153) :611-616

[3] Are β-blockers efficacious as first-line therapy for hypertension in the elderly?: A systematic review [J].

Messerli, FH ;

Grossman, E ;

Goldbourt, U .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (23) :1903-1907

[4] Blood-pressure lowering for the secondary prevention of stroke [J].

Staessen, JA ;

Wang, JG .

LANCET, 2001, 358 (9287) :1026-1027

[5]

Yusuf S, 2000, NEW ENGL J MED, V342, P145

← 1 →